We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Two white mushrooms.

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

News

Hope for Zika Treatment Found in Drug Screening

Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection.

Vitamin C May Boost Leukemia Treatment

Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.

Worms Point Way Toward Viral Strategies

Rice University wins NIH grant to study how nematodes handle gastrointestinal viruses.

Inovio Launches Zika Vaccine Trial

Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.

£4.5M Newton Fund to Tackle Antimicrobial Resistance

Six research partnerships tackling the rise of anti-microbial resistance (AMR) have been created with £4.5M investment by the UK Research Councils.

New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs

Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection

Game Changing Antibacterial Drug Research

Researchers publish report on the synthesis of a newly discovered “game-changing” antibiotic, Teixobactin.

BMG LABTECH Invests 4.5 Million Euro in Headquarters Site Expansion

Leading microplate reader manufacturer doubles its production area.

Misfiring Drugs Hit the Wrong Targets

Anti-HIV protein inhibitor drugs can bind to the wrong protein, causing unwanted side effects.

Genome Editing Without Cleaving DNA

A team involving Kobe University researchers has succeeded in developing ‘Target-AID’, a genome editing technique that does not cleave the DNA.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter